EVE Health Group Limited (ASX: EVE) - Share Price

Current share price for EVE : $0.022 0.001 (4.76%)⁺

EVE Health Group Limited (EVE), an ASX-listed company, is a vertically integrated producer of branded nutrition, health and wellness products. The Company has global reach and application to fast-growing markets across Australia and New Zealand, Asia Pacific and North America.

EVE General Information ⁺

ASX Code	EVE
Website	N/A
Industry/Sector	Packaged Foods & Meats
Market Cap ($M)	7
EVE Share Price	$0.022
Day High	$0.022
Day Low	$0.022
Last Close	$0.021
EVE Share Price Movement	$0.00 ( 4.76% )

Prices as at 16:35, 19 Jun 2026

⁺Security prices are delayed by at least 20 minutes and are indicative only.

EVE Health Group Limited (EVE) Upcoming Dividends & Yields

Distribution Type	Dividend	Franking	Ex-dividend date	Payment date	Current Price⁺	Price 7D Avg	Dividend Yield

See all dividends from EVE Health Group Limited (EVE) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

EVE Health Group Limited (EVE) price-sensitive announcements

EVE - Eve Initiates Pilot Clinical Study for Libbo ED Film

EVE Health Group Limited, an Australian life sciences company, announced the initiation of

EVE Health Group Limited (EVE)
16 Jun 2026 | 8:21 AM

EVE - Quarterly Activities/Appendix 4C Cash Flow Report

EVE Health Group Limited reported significant progress in its March 2026 quarterly update,

EVE Health Group Limited (EVE)
29 Apr 2026 | 8:13 AM

EVE - Appointment of Chief Executive Officer

EVE Health Group Limited has announced the appointment of Mr. Ben Rohr as the new Chief Ex

EVE Health Group Limited (EVE)
28 Apr 2026 | 8:15 AM

EVE - Investor Presentation

EVE Health Group Limited, an Australian company, is advancing pharmaceutical and nutraceut

EVE Health Group Limited (EVE)
26 Mar 2026 | 8:11 AM

EVE Health Group Limited (EVE) Recent ASX Announcements

Company	Sector	Market Cap ($m)	Headline	Release date/time⁺	Price at release⁺	Current price⁺	Gain/Loss
EVE Health Group Limited (EVE) ORDINARY FULLY PAID	Consumer Staple	$8	Notification of cessation of securities - EVE	19 Jun 2026 1:51PM	$0.022	$0.022	fallen by 0%
EVE Health Group Limited (EVE) ORDINARY FULLY PAID	Consumer Staple	$8	Eve Initiates Pilot Clinical Study for Libbo ED Film	16 Jun 2026 8:21AM	$0.021	$0.022	risen by 4.76%
EVE Health Group Limited (EVE) ORDINARY FULLY PAID	Consumer Staple	$8	Release of Securities from Escrow	4 Jun 2026 12:47PM	$0.022	$0.022	fallen by 0%
EVE Health Group Limited (EVE) ORDINARY FULLY PAID	Consumer Staple	$8	Change of Director's Interest Notice	22 May 2026 1:26PM	$0.025	$0.022	fallen by 12%
EVE Health Group Limited (EVE) ORDINARY FULLY PAID	Consumer Staple	$8	Notification regarding unquoted securities - EVE	8 May 2026 4:59PM	$0.029	$0.022	fallen by 24.14%
EVE Health Group Limited (EVE) ORDINARY FULLY PAID	Consumer Staple	$8	Change of Director's Interest Notice	8 May 2026 4:48PM	$0.029	$0.022	fallen by 24.14%

EVE Financial Summary

Year to Jun	NPAT	EPS	EPS chg (%)	Yield (%)	Franking (%)
2025A	-$1.45	-$1.10	-11.70%	0.00%	0.0%
2024A	-$1.58	-$1.20	-31.80%	0.00%	0.0%
2023A	-$2.30	-$1.80	-61.10%	0.00%	0.0%

EVE Peer Comparison

Company	Mkt Cap	EPS Growth (%)			P/E (%)			Dividend Yield (%)
Company	Mkt Cap	2023 A	2024 A	2025 A	2023 A	2024 A	2025 A	2023 A	2024 A	2025 A
The a2 Milk Company Limited (A2M)	$4,360M	0.2253	-0.1433	0.2606	23.2136	27.0965	21.4950	3.09%	2.61%	3.29%
Bega Cheese Limited (BGA)	$1,717M	-3.1132	0.0000	0.1754	0.0000	24.0376	20.4512	2.14%	2.67%	3.02%
Cobram Estate Olives Limited (CBO)	$1,915M	1.6604	0.0000	0.0000	35.2113	0.0000	0.0000	0.00%	0.00%	0.00%
EVE Health Group Limited (EVE)	$7M	-0.1167	0.0000	0.0000	0.0000	0.0000	0.0000	0.00%	0.00%	0.00%
Ricegrowers Limited (SGLLV)	$915M	-0.0637	0.0000	0.0000	12.9272	0.0000	0.0000	4.85%	0.00%	0.00%

EVE Directors

Name	Position	Start Date
Mr Gregory William (Bill) Fry	Executive Director, Chief Executive Officer, Managing Director	18 Aug 2009
Mr Rodney Andrew Hannington	Non-Executive Chairman, Non-Executive Director	14 Jun 2022
Dr Stuart Gunzburg	Non-Executive Director	12 Jun 2025

EVE Health Group Limited (EVE) Changes in Directors' Interest & Trades

Date of change	Director	Buy/Sell	Security Type	Qty	Trade Price	Value
21 May 2026	FRY, Gregory	Buy	Indirect Shares	850,000	$0.021	$17,850.000
8 May 2026	GUNZBURG, Stuart	Issued	Indirect Shares	500,000	$0.020	$10,000.000
2 Jan 2026	GUNZBURG, Stuart	Buy	Indirect Shares	200,000	$0.021	$4,200.000

See all changes in directors' interest & trades for EVE Health Group Limited (EVE) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

EVE Management

Name	Position
Ben Rohr	Chief Operating Officer
Steven Jackson	Company Secretary

EVE Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in EVE Health Group Limited (EVE). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding	Name
47,533,744 (19.31%)	Stuart Gunzburg

EVE Calendar of Events

Date	Event
26 February 2027	Report (Interim)
28 August 2026	Report (Annual)
28 August 2026	Report (Prelim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.

What our members say about us